-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Influenza-A-virus-IN-6
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2464415-31-2.gif)
| Category | Influenza Virus |
| CAS | 2464415-31-2 |
| Description | Influenza A virus-IN-6 (compound 16j) is a potent and selective influenza A virus inhibitor with an IC50 of 3.88 µM and CC50 of 36.64 µM. Influenza A virus-IN-6 shows anti-IAV activity with low cytotoxicity. |
Product Information
| Synonyms | Influenza A virus-IN-6|CHEMBL4778258|HY-146360|CS-0498474 |
| Molecular Weight | 409.48 |
| Molecular Formula | C25H23N5O |
| Canonical SMILES | C1CN(CC2=CC=CC=C21)C3=NC4=CC=CC=C4C(=N3)NCC(=O)NC5=CC=CC=C5 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 595 |
| Exact Mass | 409.19026037 |
| In Vitro | Influenza A virus-IN-6 (compound 16j) shows anti-influenza virus activity with an IC50 of 0.41 µM in 293T-GLUC cells. |
| Target | IC50: 3.88 µM (influenza virus); CC50: 36.64 µM (influenza virus |
| XLogP3-AA | 4.7 |
